|
Experimental Cell Research 193, 310-319.
|
|
Experimental Cell Research 193, p. 310-319
|
|
|
HIV-1-Antigen
|
|
HIV 1 Antigen
|
|
|
HIV-1-Antigen
|
|
HIV 1 antigen
|
|
|
HIV-1-Antigen-Assay
|
|
HIV-1 antigen assay
|
|
|
Delta-Antigen
|
|
Delta antigen
|
|
|
das zu standardisierende Antigen;
|
|
the antigen which is to be standardised;
|
|
|
Antigen-Nachweis im Blut.
|
|
positive antigen test on blood
|
|
|
positiver Antigen-Nachweis in Atemwegsekreten.
|
|
positive antigen test on respiratory secretions
|
|
|
Konca Solar Cell Co., Ltd
|
|
Konca Solar Cell Co. Ltd
|
|
|
ANTIGEN- UND IMPFSTOFFBANKEN
|
|
ANTIGEN AND VACCINE BANKS
|
|
|
Nationale Antigen- und Impfstoffbanken
|
|
National antigen and vaccine banks
|
|
|
Gemeinschaftliche Antigen- und Impfstoffbank
|
|
Community antigen and vaccine bank
|
|
|
Exploratory talks with a view to presenting a request to BUDG Committee to open negotiations
|
|
Exploratory talks with a view to presenting a request to BUDG Committee to open negotiations
|
|
|
- Incorporated-Cell-Unternehmen und -Gesellschaften;
|
|
- Incorporated cell companies or corporations;
|
|
|
Incorporated-Cell-Unternehmen und -Gesellschaften;
|
|
Incorporated cell companies or corporations;
|
|